Iodine Mapping Using Subtraction in Pulmonary Embolism CT Versus Dual-Energy CT

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 295 participants.

Also called NCT02890706

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 295 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02890706
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02890706. Allocation not applicable; no masking; primary purpose diagnostic. Start 2016-07-07 (actual); primary completion 2017-10-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Iodine Mapping Using Subtraction in Pulmonary Embolism CT Versus Dual-Energy CT
Acronym
InSPECT-DECT
Intervention (Device)
Iodine Mapping using Subtraction in Pulmonary Embolism Computed Tomography versus Dual Energy Computed Tomography
Lead sponsor
Radboud University Medical Center (class: other)

Record details

Record id
cardio:ct-nct02890706
Content hash
8e0602fe3e25cf395047bee7a2566f406e0f1d2aace39a62511e1d02ec8cfd2b